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Background/Introduction
In order to develop a new surgical program based on
recently developed technologies, companies often
require a minimal volume of operations. Sutureless aor-
tic bioprostheses were recently introduced in order to
make the operation simpler, faster and more user
friendly.
Aims/Objectives
The aim of this study is to review our results with the
Edwards Intuity Elite sutureless bioprosthetic aortic
valve.
Methods
The perioperative data of patients who underwent aortic
valve replacement during the last year by sutureless bio-
protheses (Edwards Intuity Elite, n = 7) were reviewed
retrospectively and compared to those who received a
conventional bioprostheses (Edwards Perimount Magna
Ease, n = 7).
Results
Patients in the Intuity group were significantly older
(76 vs. 64 years), but didn’t differ significantly with
regards to EuroSCORE-II or comorbidities. The opera-
tive times didn’t differ significantly between groups,
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Table 1
Intuity group (n = 7) Conventional group (n = 7) *p
Median Min.-Max. Median Min.-Max.
Age (years) 76 71-79 64 43-82 0.035
Euroscore II 6.48 2.56-10.55 3.41 1.53-8.97 >0.05
CBP time (min) 102 58-218 102 60-158 >0.05
Crossclamp time (min) 78 45-133 79 52-118 >0.05
Valve size 21 21-27 25 23-27 >0.05
Concomitant procedures 4 2
Aortic Valve Gradients (mmHg) Preop Max. 71 30-95 49 28-106 >0.05
Preop Mean 46.50 16-61 29.50 21-51 >0.05
Postop Max. 15.50 8-19 26 18-47 0.006
Postop Mean 9 7-13 14 9-24 0.046
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even though more patients in the Intuity group had
concomitant procedures. No valvular and paravalvular
leak or heart block were seen after the operation in
both groups. Despite the median valve size being smal-
ler in the Intuity group (21 vs. 25 mm), the postopera-
tive gradients were significantly lower.
Conclusion
New sutureless aortic bioprostheses were safe and effective
for the surgical treatment of severe aortic stenosis and
provided better hemodynamic results. During this intial
learning curve, operative times didn’t differ between
groups, no per- or post-operative complications were
observed. The adoption of new technologies doesn’t
require high volume, provided it is conducted by the same
familiar team in a step-by-step way.
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